|Outsourcing OutlookEric LangerYear in Review: Trends in Biopharma Manufacturing Outsourcing|
|Regulatory WatchJill WechslerFDA Realigns Drug Inspection and Manufacturing Oversight|
|Ask The ExpertSiegfried Schmitt Good Distribution Practices: Who is Responsible?|
EMA Recommends Suspension of 700 Drugs Tested at GVK Site GVK Biosciences argues that EMA’s recommended suspension of 700 drugs is disproportional to reported infractions.
Nelson Patterson has been elected to Pharma & Biopharma Outsourcing Association board.
There are significant differences between small molecules and biologics fill/finish capacity.